title: Severe perioperative bleeding in renal cell carcinoma after elective pericardiocentesis associated left ventricular puncture: case report.
abstract: In the United States during the year 2015, approximately 61,560 patients are expected to be diagnosed with kidney cancer and 14,080 to die from the disease. We present the case of a patient with renal cell carcinoma who suffered severe perioperative bleeding and coagulopathy after emergency sternotomy. We also engage in relevant aspects of perioperative anesthesia care including the considerations and management of coagulopathy, liver failure and renal failure in the oncologic patient. The case is a 49-year-old man with vena cava tumor thrombus who underwent radiologic tumor embolization, left radical nephrectomy, and inferior vena cava (IVC) thrombectomy. Postoperatively, he developed sepsis, multiple organ failure, and a pericardial effusion requiring pericardiocentesis. During pericardiocentesis, he suffered an iatrogenic left entricular perforation, requiring an emergency sternotomy and left ventricular repair. Cancer patients are often challenging for surgical and anesthesia teams, emergency care requires an organized and comprehensive approach. The use of recombinant factor VIIa NovoSeven can help in managing severe postoperative bleeding after cardiothoracic surgery in oncologic patients, but further studies should be done to confirm this.
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Address: Holcombe Boulevard 1515, Houston, Texas, United States. Email: jlasala@mdanderson.org.
authors.forename: Javier
authors.initials: J
authors.lastname: Lasala
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: Miguel Alejandro
authors.initials: MA
authors.lastname: Patino
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Mena
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: Shital
authors.initials: S
authors.lastname: Vachhani
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: Teresa
authors.initials: T
authors.lastname: Moon
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: Thao
authors.initials: T
authors.lastname: Bui
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
authors.forename: January
authors.initials: J
authors.lastname: Tsai
mesh_terms: D016063:Blood Loss, Surgical; D002292:Carcinoma, Renal Cell / Q000601:surgery*; D006335:Heart Injuries / Q000209:etiology; D006352:Heart Ventricles / Q000293:injuries; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000379:methods; D020519:Pericardiocentesis / Q000379:methods*; D012720:Severity of Illness Index; D056346:Sternotomy / Q000379:methods; D017131:Thrombectomy / Q000379:methods
keywords: hemorrhage; pericardiocentesis; perioperative care; renal cell carcinoma